Neogenomics

Neogenomics Dividend Growth

Year-over-Year Dividend Growth of Neogenomics (NEO) as of Oct 27, 2026.

Dividend Growth

-

Last updated:

Year-over-Year Dividend Growth of Neogenomics is 2026 - . Year-over-Year Dividend Growth of Neogenomics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neogenomics Stock analysis

What does Neogenomics do? Neogenomics Inc. is a leading company in the field of personalized medicine, based in Fort Myers, Florida. It offers integrated diagnostics and pharmaceutical services for oncology and gene therapy, with a focus on providing accurate diagnosis for cancer patients. Neogenomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neogenomics stock

On Eulerpool you can find the complete historical development of Year-over-Year Dividend Growth Neogenomics since 2006 – with annual values, charts, and detailed analysis.

Dividend growth measures the percentage increase in dividends compared to the previous year. Consistent dividend growth signals financial strength and shareholder commitment.

To evaluate Year-over-Year Dividend Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Dividend Growth.

Year-over-Year Dividend Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Dividend Growth's Neogenomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Neogenomics

All Key Metrics — Neogenomics